A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells.

Pharm Res 2006 Jul 24;23(7):1574-85. Epub 2006 Jun 24.

Leslie Dan Faculty of Pharmacy, University of Toronto, 19 Russell Street, Toronto, Ontario, Canada, M5S 2S2.

Purpose: This work is intended to develop and evaluate a new polymer-lipid hybrid nanoparticle system that can efficiently load and release water-soluble anticancer drug doxorubicin hydrochloride (Dox) and enhance Dox toxicity against multidrug-resistant (MDR) cancer cells.

Methods: Cationic Dox was complexed with a new soybean-oil-based anionic polymer and dispersed together with a lipid in water to form Dox-loaded solid lipid nanoparticles (Dox-SLNs). Drug loading and release properties were measured spectrophotometrically. The in vitro cytotoxicity of Dox-SLN and the excipients in an MDR human breast cancer cell line (MDA435/LCC6/MDR1) and its wild-type line were evaluated by trypan blue exclusion and clonogenic assays. Cellular uptake and retention of Dox were determined with a microplate fluorometer.

Results: Dox-SLNs were prepared with a drug encapsulation efficiency of 60-80% and a particle size range of 80-350 nm. About 50% of the loaded drug was released in the first few hours and an additional 10-20% in 2 weeks. Treatment of the MDR cells with Dox-SLN resulted in over 8-fold increase in cell kill when compared to Dox solution treatment at equivalent doses. The blank SLN and the excipients exhibited little cytotoxicity. The biological activity of the released Dox remained unchanged from fresh, free Dox. Cellular Dox uptake and retention by the MDR cells were both significantly enhanced (p < 0.05) when Dox was delivered in Dox-SLN form.

Conclusions: The new polymer-lipid hybrid nanoparticle system is effective for delivery of Dox and enhances its efficacy against MDR breast cancer cells.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11095-006-0282-xDOI Listing
July 2006
33 Reads

Publication Analysis

Top Keywords

nanoparticle system
12
breast cancer
12
hybrid nanoparticle
12
polymer-lipid hybrid
12
dox
10
mdr cells
8
cancer cells
8
uptake retention
8
human breast
8
mdr
5
trypan blue
4
remained unchanged
4
mda435/lcc6/mdr1 wild-type
4
dox remained
4
wild-type evaluated
4
evaluated trypan
4
activity released
4
cellular uptake
4
retention dox
4
biological activity
4

Altmetric Statistics

References

(Supplied by CrossRef)

P. E. Lonning et al.
Lancet Oncol. 2003

Early Breast Cancer Trialists' Collaborative Group et al.
Lancet 1998

M. M. Gottesman et al.
Annu. Rev. Med. 2002

F. Leonessa et al.
Endocr.-Relat. Cancer 2003

I. Mohamed et al.
2003

H. C. Chung et al.
Breast Cancer Res. Tr. 1967

Z. Liu et al.
J. Pharm. Sci. 1999

R. Y. Cheung et al.
Anti-Cancer Drugs 2005

R. Cheung et al.
Biomaterials 2005

Z. Liu et al.
J. Control. Release 2001

S. C. J. Steiniger et al.
Int. J. Cancer 2004

Similar Publications